Immunosenescence: emerging challenges for an ageing population

By D. Aw, Alberto B. Silva, D. Palmer. Immunology, 2007

830 citations recorded by the source corpus.

Subfields: Epidemiology, Immunology

View Paper: https://www.semanticscholar.org/paper/993262bf293fec94ca7e7cf9c5b34e2cbd95504d

Citations in the corpus

• Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge (2008, neutral): “This may be due to an impaired innate immune system in the elderly (1) or to differences in the efficiency of the human MAbs at reaching the lung mucosa and neutralizing the virus.”
• Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (2020, neutral): “A similar pattern was seen across the age groups in participants after their prime vaccination with low-dose ChAdOx1 nCoV-19 and after the boost vaccination with the low-dose vaccine, but with fewer total adverse reactions than in the standard-dose groups (appendix pp 7, 9, 19–21).”